enGene Therapeutics Inc. (ENGN, ENGNW)

CIK 1980845 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for enGene Therapeutics Inc..

Recent SEC filings

FiledFormAccession number
Sep 8, 20268-K0001193125-26-384380
Sep 8, 202610-Q0001193125-26-384383
Aug 14, 2026SCHEDULE 13G/A0001193125-26-352637
Aug 14, 2026SCHEDULE 13G/A0001172661-26-003477
Aug 14, 2026SCHEDULE 13G/A0001231919-26-000931
Aug 13, 2026SCHEDULE 13G/A0002005369-26-000051
Aug 12, 2026SCHEDULE 13G/A0001140361-26-032512
Aug 11, 20268-K0001193125-26-344559
Jul 22, 202630000929638-26-002666
Jul 22, 202630000929638-26-002667
Jul 22, 2026SCHEDULE 13G0001636587-26-000058
Jul 17, 20268-K0001193125-26-307795
Jul 16, 20268-K0001193125-26-305418
Jun 18, 20268-K/A0001193125-26-275815
Jun 17, 202640000929638-26-002260
Jun 17, 202640000929638-26-002263
Jun 17, 202640000929638-26-002262
Jun 17, 202640000929638-26-002256
Jun 17, 202640000929638-26-002257
Jun 17, 202640000929638-26-002258
Jun 17, 202640000929638-26-002261
Jun 17, 202640000929638-26-002259
Jun 15, 202610-Q0001193125-26-270386
Jun 15, 20268-K0001193125-26-270384
Jun 10, 20268-K0001193125-26-265830